"use strict";(self.webpackChunkdocs=self.webpackChunkdocs||[]).push([[3],{7653:(e,n,t)=>{t.r(n),t.d(n,{assets:()=>c,contentTitle:()=>o,default:()=>h,frontMatter:()=>a,metadata:()=>r,toc:()=>d});var s=t(4848),i=t(8453);const a={output:"docusaurus-md",sidebar_position:3,description:"An example with two phenotypes in a consanguineous family."},o="3) Two phenotypes {#two-phenotypes}",r={id:"examples/example3",title:"3) Two phenotypes",description:"An example with two phenotypes in a consanguineous family.",source:"@site/docs/examples/example3.md",sourceDirName:"examples",slug:"/examples/example3",permalink:"/shinyseg/examples/example3",draft:!1,unlisted:!1,tags:[],version:"current",sidebarPosition:3,frontMatter:{output:"docusaurus-md",sidebar_position:3,description:"An example with two phenotypes in a consanguineous family."},sidebar:"tutorialSidebar",previous:{title:"2) X-linked inheritance",permalink:"/shinyseg/examples/example2"},next:{title:"4) Breast cancer and BRCA1",permalink:"/shinyseg/examples/example4"}},c={},d=[{value:"Pedigree table",id:"pedigree-table",level:2},{value:"Simplified models",id:"simplified-models",level:2},{value:"Accounting for ages",id:"accounting-for-ages",level:2}];function l(e){const n={a:"a",code:"code",em:"em",h1:"h1",h2:"h2",p:"p",pre:"pre",...(0,i.R)(),...e.components};return(0,s.jsxs)(s.Fragment,{children:[(0,s.jsx)(n.h1,{id:"two-phenotypes",children:"3) Two phenotypes"}),"\n",(0,s.jsx)(n.p,{children:"This example demonstrates how to incorporate multiple phenotypes into\nthe cosegregation analysis. It also showcases how the app can deal with\nconsanguineous families."}),"\n",(0,s.jsx)(n.h2,{id:"pedigree-table",children:"Pedigree table"}),"\n",(0,s.jsx)(n.p,{children:"The data corresponding to the case is shown below:"}),"\n",(0,s.jsx)(n.pre,{children:(0,s.jsx)(n.code,{className:"language-text",children:" ped id fid mid sex phenotype carrier proband age\n   1  1   0   0   1         .       .       .  50\n   1  2   0   0   2         .       .       .  50\n   1  3   1   2   1         .       .       .  50\n   1  4   0   0   2      mild       .       .  50\n   1  5   1   2   1         .       .       .  50\n   1  6   0   0   2    nonaff       .       .  50\n   1  7   3   4   1    severe     het       .  50\n   1  8   0   0   2    nonaff       .       .  50\n   1  9   5   6   1      mild       .       .  50\n   1 10   0   0   2    nonaff       .       .  50\n   1 11   7   8   1    nonaff       .       .  50\n   1 12   9  10   2      mild     het       .  50\n   1 13  11  12   1    severe     het       1  50\n   1 14  11  12   2      mild     het       .  50\n   1 15  11  12   2    nonaff     neg       .  50\n"})}),"\n",(0,s.jsx)("img",{src:t(7575).A,style:{maxHeight:"350px"}}),"\n",(0,s.jsx)(n.p,{children:"In this family, there are two disease phenotypes: one relatively mild\nand common, and one more rare and severe. It is hypothesized that the\nrare autosomal variant found in some members (indicated by + or \u2013) could\nbe associated with increased risks for both."}),"\n",(0,s.jsx)(n.h2,{id:"simplified-models",children:"Simplified models"}),"\n",(0,s.jsxs)(n.p,{children:["In a first approach, we will ignore onset/censoring ages by switching to\nthe ",(0,s.jsx)(n.code,{children:"Liability class"})," mode and declaring age-independent classes."]}),"\n",(0,s.jsx)(n.p,{children:"The most basic strategy would be to also disregard the distinction\nbetween both phenotypes and treat both as the same \u201caffected\u201d. For\ninstance, let\u2019s assume that we suspect the phenocopy rate and penetrance\nfor the mild phenotype to be 20% and 70%, respectively, and we decide to\napply these values to all pedigree members:"}),"\n",(0,s.jsx)("img",{src:t(9595).A,style:{maxHeight:"185px"}}),"\n",(0,s.jsx)(n.p,{children:"With this setup, we would obtain moderate evidence for pathogenicity, as\nshown below. The sensitivity analysis also indicates that increasing the\nratio of the penetrance-to-phenocopy rate would increase the evidence."}),"\n",(0,s.jsx)("img",{src:t(8954).A,style:{maxHeight:"550px"}}),"\n",(0,s.jsxs)(n.p,{children:["However, we should account for the differences between both phenotypes,\nif they exist. Luckily, this can be easily done by adding more liability\nclasses and specifying the cases to which they apply. For instance, in\nthe following, we set a phenocopy rate and penetrance for the severe\nphenotype of 1% and 25%, respectively. Notice that now we also need to\nspecify the parameters for the \u201cnonaffected\u201d phenotype (",(0,s.jsx)(n.code,{children:"nonaff"}),"), which\nrefer to the risk for ",(0,s.jsx)(n.em,{children:"any"})," of the disease phenotypes."]}),"\n",(0,s.jsx)("img",{src:t(4824).A,style:{maxHeight:"225px"}}),"\n",(0,s.jsx)(n.p,{children:"And with that, the FLB shoots to 45.3, resulting in strong evidence for\npathogenicity."}),"\n",(0,s.jsx)("img",{src:t(5169).A,style:{maxHeight:"150px"}}),"\n",(0,s.jsx)(n.h2,{id:"accounting-for-ages",children:"Accounting for ages"}),"\n",(0,s.jsxs)(n.p,{children:["Now, let\u2019s complicate the model by considering the ages (of onset or\ncensoring) shown below each pedigree member. This can be done by\ndeclaring age-specific liability classes, but it can quickly get\ncumbersome. To do it, we will switch back to the ",(0,s.jsx)(n.code,{children:"Relative risk"})," mode."]}),"\n",(0,s.jsxs)(n.p,{children:["In this mode, we cannot overlook the distinction between both\nphenotypes; we must specify the parameters for both. In the following,\nwe use the same risk values (now referring to lifetime risks) as before.\nAdditionally, we consider that phenocopies have an expected onset at\n75\xb120 years of age for the mild phenotype and 60\xb115 years for the severe\none. Notice that for the former, we also specify that the risk conferred\nby the variant is higher at middle ages; you can find further details on\nhow to do this ",(0,s.jsx)(n.a,{href:"/how-to/penetrance#hazard-ratios",children:"here"}),"."]}),"\n",(0,s.jsx)("img",{src:t(7185).A,style:{maxHeight:"500px"}}),"\n",(0,s.jsx)(n.p,{children:"After accounting for the age data, cosegregation evidence is reduced\nconsiderably, although it remains strong (FLB > 32)."}),"\n",(0,s.jsx)("img",{src:t(7868).A,style:{maxHeight:"150px"}})]})}function h(e={}){const{wrapper:n}={...(0,i.R)(),...e.components};return n?(0,s.jsx)(n,{...e,children:(0,s.jsx)(l,{...e})}):l(e)}},8954:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex3-lclass1-flb-2b757ea09ae239fbfdd9053e8d33aef3.png"},9595:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex3-lclass1-tab-eca12be8ea017e7d213d0bd685414fdb.png"},5169:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex3-lclass2-flb-92b8bc4f7af283fbe76c165df510fe5b.png"},4824:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex3-lclass2-tab-c6f2e58a79cb74ed4cde90d192ffdf59.png"},7575:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex3-ped-0061b0ac6f8cdcf649fd29275d6b6470.png"},7868:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex3-rrisk-flb-66a2915e989a0dba1a3bc6fc8b243728.png"},7185:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex3-rrisk-tab-00c3df49266aad95a6fc4bd23fff7f8e.png"},8453:(e,n,t)=>{t.d(n,{R:()=>o,x:()=>r});var s=t(6540);const i={},a=s.createContext(i);function o(e){const n=s.useContext(a);return s.useMemo((function(){return"function"==typeof e?e(n):{...n,...e}}),[n,e])}function r(e){let n;return n=e.disableParentContext?"function"==typeof e.components?e.components(i):e.components||i:o(e.components),s.createElement(a.Provider,{value:n},e.children)}}}]);